Join the 200th Anniversary Celebration
Bevacizumab and HER2-Negative Breast Cancer
original article

Bevacizumab added to neoadjuvant combination chemotherapy increased the rate of pathological complete response among patients with HER2-negative early-stage breast cancer. The effect was greatest in patients with the poorest prognosis, those with so-called triple-negative tumors.

  • CME
  • Comments
original article
Specialties Hematology/Oncology
editorial
Lifetime Risks of Cardiovascular Disease
original article

Data from more than 250,000 men and women in 18 cohort studies were used to calculate the lifetime risk of cardiovascular events, stratified according to risk-factor burden, with adjustment for the competing risk of death from noncardiovascular causes.

Specialties Cardiology
Thumbnail Graphic -- Health Policy and Reform Center
perspective Online First
  • Comments
perspective Online First
  • Comments

Featured Multimedia

Current Issue: January 26, 2012

Weekly Audio Summary

Browse Past Issues
original articles
  • CME
  • Comments
Published Online: January 11, 2012
clinical therapeutics
  • CME
review article
  • CME
images in clinical medicine
  • Free Full Text
  • Free Full Text
  • Video
case records of the massachusetts
general hospital
clinical implications of basic research

Perspective

The Sources of the SGR 'Hole'
Published Online: December 21, 2011
  • Free Full Text
  • Audio Interview
  • Comments
  • Free Full Text
Published Online: December 21, 2011
  • Free Full Text
Published Online: January 11, 2012
  • Free Full Text
  • Comments

Online First

perspective
perspective
perspective

More Online First Articles

Image Challenge

Image Challenge

What is the diagnosis?

Image of the Week

Tripe Palms

A 56-year-old smoker presented with cough and weight loss. The palms had a raised velvety texture, and there was clubbing.

Recent Featured Images